We are live on ! Find out more
ETNB

89bio

Delisted

ETNB was delisted on the 29th of October, 2025.

184 hedge funds and large institutions have $1.58B invested in 89bio in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 56 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 56

39% more capital invested

Capital invested by funds: $1.14B → $1.58B (+$444M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

4.7% more ownership

Funds ownership: 105.72%110.42% (+4.7%)

6% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 33

1% less funds holding

Funds holding: 186184 (-2)

79% less call options, than puts

Call options by funds: $3.66M | Put options by funds: $17.4M

Holders
184
Holders Change
-2
Holders Change %
-1.08%
% of All Funds
2.42%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
31
Increased
80
Reduced
56
Closed
33
Calls
$3.66M
Puts
$17.4M
Net Calls
-$13.7M
Net Calls Change
-$9.12M

ETNB Hedge Fund Activity: Q2 2025 in Review

184 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q2 2025, worth a combined $1.58B — up 39% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of ETNB and 31 opened new positions — a net loss of 2 holders — while 56 trimmed existing stakes and 80 added.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $25.4M. The largest seller was Logos Global Management, exiting entirely with an estimated $18.2M sold.

  • 184 institutional investors held 89bio (ETNB) as of Q2 2025, down from 186 in Q1 2025.
  • Funds reported $1.58B of 89bio stock for Q2 2025, up 39% quarter-over-quarter.
  • 31 funds opened new 89bio positions in Q2 2025 and 33 closed out, a net change of -2 holders.
  • The largest 89bio buyer in Q2 2025 was Holocene Advisors, an estimated $25.4M added.
  • The largest 89bio seller in Q2 2025 was Logos Global Management, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2025.